University of California San Francisco
Give to UCSF
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
Over the past four decades, UCSF has led the way in its heroic response to the AIDS epidemic, both locally and globally. This timeline covers some of the highlights at UCSF, in the nation and around the world after a mysterious disease affecting gay men was first reported on June 5, 1981.
The Hellman Foundation has given a $12 million endowment to support the Hellman Fellows Fund in perpetuity.
Researchers from the UCSF School of Nursing have joined a newly launched national collaborative to study the impacts of COVID-19 on members of the lesbian, gay, bisexual, transgender and queer communities.
Six health care experts grapple with how to address race without being racist.
Fifteen faculty, staff and students were honored for their public service, excellence in nursing and exceptional service to UC San Francisco at this year’s UCSF Founders Day Awards event.
This year’s Chancellor’s Diversity Forum provided updates on a wide array of ongoing diversity and anti-racism efforts at UC San Francisco and a chance for the University community to ask questions.
Knowing the whole story matters. That idea was at the heart of the 2021 UCSF Last Lecture, delivered by Peter Chin-Hong, MD, associate dean and professor in the School of Medicine. The last
In the third installment of UCSF’s three-part series, “COVID-19: The Path Forward,” a panel of health and policy experts met March 23 to examine COVID-19's impact on our society and look ahead to how we rebuild and prepare for future pandemics.
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
UC San Francisco and Johns Hopkins University today announced the launch of the Opioid Industry Documents Archive, a digital repository of publicly disclosed documents from recent judgments, settlements, and ongoing lawsuits concerning the opioid crisis.
